MLAB - Mesa Laboratories, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
269.70
+2.00 (+0.75%)
At close: 4:00PM EST

269.70 0.00 (0.00%)
After hours: 4:00PM EST

Stock chart is not supported by your current browser
Previous Close267.70
Open267.00
Bid269.28 x 800
Ask270.28 x 800
Day's Range266.18 - 270.21
52 Week Range181.21 - 271.11
Volume26,222
Avg. Volume38,421
Market Cap1.188B
Beta (5Y Monthly)0.25
PE Ratio (TTM)261.59
EPS (TTM)1.03
Earnings DateFeb 09, 2020
Forward Dividend & Yield0.64 (0.24%)
Ex-Dividend DateFeb 26, 2020
1y Target Est273.75
  • GlobeNewswire

    Mesa Labs Reports Third Quarter Results

    LAKEWOOD, Colo., Feb. 10, 2020 -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, or “Mesa Labs”) today reported third quarter results for the three months ended December.

  • Why We’re Not Keen On Mesa Laboratories, Inc.’s (NASDAQ:MLAB) 5.0% Return On Capital
    Simply Wall St.

    Why We’re Not Keen On Mesa Laboratories, Inc.’s (NASDAQ:MLAB) 5.0% Return On Capital

    Today we are going to look at Mesa Laboratories, Inc. (NASDAQ:MLAB) to see whether it might be an attractive...

  • Mesa Labs (MLAB) Earnings Expected to Grow: Should You Buy?
    Zacks

    Mesa Labs (MLAB) Earnings Expected to Grow: Should You Buy?

    Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire

    MESA LABS DECLARES QUARTERLY DIVIDEND

    LAKEWOOD, Colo., Jan. 09, 2020 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. Mesa is a global technology innovator committed to solving some of the most critical quality control challenges in the pharmaceutical, healthcare, industrial safety, environmental and food and beverage industries. Mesa offers products and services through five divisions (Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, Cold Chain Monitoring and Cold Chain Packaging) to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.

  • Is Mesa Laboratories, Inc. (MLAB) A Good Stock To Buy ?
    Insider Monkey

    Is Mesa Laboratories, Inc. (MLAB) A Good Stock To Buy ?

    The market has been volatile in the last few months as the Federal Reserve finalized its rate cuts and uncertainty looms over trade negotiations with China. Small cap stocks have been hit hard as a result, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by more than 10 percentage […]

  • Mesa Labs (MLAB) Q2 Earnings Top Estimates
    Zacks

    Mesa Labs (MLAB) Q2 Earnings Top Estimates

    Mesa Labs (MLAB) delivered earnings and revenue surprises of 0.58% and -1.79%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Mesa Labs Reports Record Second Quarter Revenues and Adjusted Operating Income

    LAKEWOOD, Colo., Nov. 06, 2019 -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record second quarter revenues and adjusted.

  • GlobeNewswire

    Mesa Labs Acquires Gyros Protein Technologies

    LAKEWOOD, Colo., Oct. 31, 2019 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (MLAB) (we, us, our, “Mesa” or the “Company”), a diversified supplier of quality control instruments and consumables to highly regulated markets today announced the acquisition of Gyros Protein Technologies Holding AB (“GPT”). GPT is headquartered in Uppsala, Sweden and is a leading provider of Immunoassay and Peptide Synthesis solutions that accelerate the discovery, development and manufacturing of biotherapeutics. The acquisition deepens our commitment to biopharmaceutical quality control and will be the core of our new platform, Biopharmaceutical Development.

  • Hedge Funds Are Dumping Mesa Laboratories, Inc. (MLAB)
    Insider Monkey

    Hedge Funds Are Dumping Mesa Laboratories, Inc. (MLAB)

    We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always […]

  • Mesa Labs (MLAB) Earnings Expected to Grow: What to Know Ahead of Q2 Release
    Zacks

    Mesa Labs (MLAB) Earnings Expected to Grow: What to Know Ahead of Q2 Release

    Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • The Mesa Laboratories (NASDAQ:MLAB) Share Price Is Up 205% And Shareholders Are Boasting About It
    Simply Wall St.

    The Mesa Laboratories (NASDAQ:MLAB) Share Price Is Up 205% And Shareholders Are Boasting About It

    It might be of some concern to shareholders to see the Mesa Laboratories, Inc. (NASDAQ:MLAB) share price down 15% in...

  • Mesa Laboratories (NASDAQ:MLAB) Seems To Use Debt Quite Sensibly
    Simply Wall St.

    Mesa Laboratories (NASDAQ:MLAB) Seems To Use Debt Quite Sensibly

    Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

  • GlobeNewswire

    Mesa Laboratories, Inc. Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

    Mesa Laboratories, Inc. (MLAB) (“Mesa”) today announced the pricing of concurrent underwritten public offerings of (a) 375,000 shares of its common stock at a public offering price of $210.00 per share for gross proceeds, before deducting underwriting discounts and commissions and estimated offering expenses, of approximately $78.8 million and (b) $150 million aggregate principal amount of its 1.375% convertible senior notes due 2025 (the “notes”). In addition, Mesa has granted (a) the underwriters of the common stock offering a 30-day option to purchase up to 56,250 additional shares and (b) the underwriters of the notes offering a 13-day option to purchase up to $22.5 million aggregate principal amount of additional notes. The offering of the shares is expected to result in approximately $73.9 million in net proceeds to Mesa after deducting underwriting discounts and commissions and other estimated offering expenses payable by Mesa (assuming no exercise of the underwriters’ option to purchase additional shares).

  • GlobeNewswire

    Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock and Convertible Senior Notes

    Mesa Laboratories, Inc. (MLAB) (“Mesa”) today announced that it has commenced concurrent underwritten public offerings of 375,000 shares of its common stock and $150 million aggregate principal amount of its convertible senior notes due 2025 (the “notes”). In addition, Mesa expects to grant (a) the underwriters of the common stock offering a 30-day option to purchase up to 56,250 additional shares and (b) the underwriters of the notes offering a 13-day option to purchase up to $22.5 million aggregate principal amount of additional notes.

  • Is Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 6.6% ROE Worse Than Average?
    Simply Wall St.

    Is Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 6.6% ROE Worse Than Average?

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

  • Mesa Labs (MLAB) Beats Q1 Earnings and Revenue Estimates
    Zacks

    Mesa Labs (MLAB) Beats Q1 Earnings and Revenue Estimates

    Mesa Labs (MLAB) delivered earnings and revenue surprises of 7.18% and 2.29%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Mesa Labs Reports Record First Quarter Revenues and Adjusted Operating Income

    LAKEWOOD, Colo., July 30, 2019 -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record first quarter revenues and adjusted.

  • Earnings Preview: Mesa Labs (MLAB) Q1 Earnings Expected to Decline
    Zacks

    Earnings Preview: Mesa Labs (MLAB) Q1 Earnings Expected to Decline

    Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Hedge Funds Have Never Been More Bullish On Mesa Laboratories, Inc. (MLAB)
    Insider Monkey

    Hedge Funds Have Never Been More Bullish On Mesa Laboratories, Inc. (MLAB)

    Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of March. At Insider Monkey, we follow nearly 750 active hedge funds and notable investors and by analyzing their 13F filings, we can determine the stocks that they are […]

  • PR Newswire

    MarketAxess Holdings Set to Join S&P 500; Axon Enterprise to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK , June 24, 2019 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600:   S&P MidCap 400 constituent MarketAxess Holdings Inc. ...

  • Why You Should Like Mesa Laboratories, Inc.’s (NASDAQ:MLAB) ROCE
    Simply Wall St.

    Why You Should Like Mesa Laboratories, Inc.’s (NASDAQ:MLAB) ROCE

    Today we'll look at Mesa Laboratories, Inc. (NASDAQ:MLAB) and reflect on its potential as an investment. Specifically...

  • Associated Press

    Mesa Labs: Fiscal 4Q Earnings Snapshot

    The Lakewood, Colorado-based company said it had net income of 34 cents per share. Earnings, adjusted for stock option expense and amortization costs, were $1.75 per share. The quality control instruments ...

  • GlobeNewswire

    Mesa Labs Reports Record Revenues and Adjusted Operating Income for Fiscal Year 2019

    LAKEWOOD, Colo., June 03, 2019 -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues and adjusted operating income1 for.